Keyword search (4,163 papers available)

"Li P" Authored Publications:

Title Authors PubMed ID
1 Associations between brain and cognitive resilience, tau load and extent in Alzheimer's disease Mitchell SW; Chan T; Trudel L; Hosseini SA; Macedo AC; Gonçalves MP; Rahmouni N; Hall BJ; Socualaya KMQ; Therriault J; Servaes S; Bezgin G; Zheng Y; Aumont E; Wang YT; Arias JF; Real APB; Jia WL; Hopewell R; Hsiao C; Soucy JP; Vitali P; Pascoal TA; Rosa-Neto P; 41512332
PERFORM
2 Alzheimer s Imaging Consortium Mitchell SW; Chan T; Trudel L; Hosseini SA; Macedo AC; Gonçalves MP; Rahmouni N; Hall BJ; Socualaya KMQ; Therriault J; Servaes S; Bezgin G; Zheng Y; Aumont E; Wang YT; Arias JF; Real APB; Jia WL; Hopewell R; Hsiao C; Soucy JP; Vitali P; Pascoal TA; Rosa-Neto P; 41433447
PERFORM
3 Trends in missed paediatric preventive primary care visits during the COVID-19 pandemic using routinely collected electronic medical records in Ontario, Canada (2015-2022) Bayoumi I; Mcfadden K; Valkanas H; Tu K; Kalia S; Chen T; Christie CD; Rourke J; Rourke L; Greiver M; Leduc D; Li P; 41290264
CONCORDIA
4 Investigating the effects of a randomized, double-blinded aerobic, resistance, and cognitive training clinical trial on neurocognitive function in older adults with cardiovascular risk factors: the ACTIONcardioRisk protocol Bherer L; Vrinceanu T; Dupuy EG; Gayda M; Vincent T; Magnan PO; Mohammadi H; Gauthier C; Gagnon C; Duchesne S; Erickson KI; Gagnon D; Lesage F; Lupien S; Poirier J; Dubé MP; Thorin É; Juneau M; Breton J; Belleville S; Ferland G; Gaudreau-Majeau F; Blanchette CA; Vitali P; Nigam A; 40625372
PSYCHOLOGY
5 Adaptive finite-time synchronized control of multi-robotic fiber placement system with model uncertainties and disturbances Zhang R; Wang Y; Xie W; Li P; Tan H; Jiang Y; 40461302
ENCS
6 Dynamic and Reprocessable Fluorinated Poly(hindered urea) Network Materials Containing Ionic Liquids to Enhance Triboelectric Performance Nellepalli P; Kim MP; Park J; Noh SM; Ye Z; Jung HW; Ko H; Oh JK; 35385641
CHEMBIOCHEM
7 Dynamic Covalent Polyurethane Network Materials: Synthesis and Self-healability Nellepalli P; Patel T; Oh JK; 34418209
CHEMBIOCHEM
8 Macromolecularly Engineered Thermoreversible Heterogeneous Self-Healable Networks Encapsulating Reactive Multidentate Block Copolymer-Stabilized Carbon Nanotubes Zhang G; Patel T; Nellepalli P; Bhagat S; Hase H; Jazani AM; Salzmann I; Ye Z; Oh JK; 33988899
CHEMBIOCHEM
9 Self-Healable Reprocessable Triboelectric Nanogenerators Fabricated with Vitrimeric Poly(hindered Urea) Networks. Patel T, Kim MP, Park J, Lee TH, Nellepalli P, Noh SM, Jung HW, Ko H, Oh JK 32840992
CHEMBIOCHEM
10 Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children. Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, H 32389335
HKAP
11 Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Leung AA, Nerenberg K, Daskalopoulou SS, McBrien K, Zarnke KB, Dasgupta K, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GV, Lebel M, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell NR, Moe GW, Howlett JG, Boulanger JM, Prebtani A, Laroc 27118291
HKAP
12 Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, Nerenberg K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Tran KC, Tobe SW, Ruzicka M, Burns KD, Vallée M, Prasad GVR, Gryn SE, Feldman RD, Selby P, Pipe A, Schiffrin EL, McFarlane PA, Oh P, Hegele RA, Khara M, Wilson TW, Penner SB, Burgess E, Sivapalan P, Herman RJ, Bacon SL, Rabkin SW, Gilbert RE, Campbell TS, Grover S, Honos G, Lindsay P, Hill MD, Coutts SB, Gubitz G, Campbell 28449828
HKAP
13 Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Nerenberg KA, Zarnke KB, Leung AA, Dasgupta K, Butalia S, McBrien K, Harris KC, Nakhla M, Cloutier L, Gelfer M, Lamarre-Cliche M, Milot A, Bolli P, Tremblay G, McLean D, Padwal RS, Tran KC, Grover S, Rabkin SW, Moe GW, Howlett JG, Lindsay P, Hill MD, Sharma M, Field T, Wein TH, Shoamanesh A, Dresser GK, Hamet P, Herman RJ, Burgess E, Gryn SE, Grégoire JC, Lewanczuk R, Poirier L, Campbell TS, Feldman RD, Lavoie KL, Tsuyuki RT, Honos G, Prebtani APH, Kline G, Schiffrin EL, Don-Wauchope A, Tobe SW, Gilbert RE, 29731013
NA

 

Title:Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.
Authors:Rabi DMMcBrien KASapir-Pichhadze RNakhla MAhmed SBDumanski SMButalia SLeung AAHarris KCCloutier LZarnke KBRuzicka MHiremath SFeldman RDTobe SWCampbell TSBacon SLNerenberg KADresser GKFournier ABurgess ELindsay PRabkin SWPrebtani APHGrover SHonos GAlfonsi JEArcand JAudibert FBenoit GBittman JBolli PCôté AMDionne JDon-Wauchope AEdwards CFiroz TGabor JYGilbert REGrégoire JCGryn SEGupta MHannah-Shmouni FHegele RAHerman RJH
Link:https://www.ncbi.nlm.nih.gov/pubmed/32389335?dopt=Abstract
DOI:10.1016/j.cjca.2020.02.086
Publication:The Canadian journal of cardiology
Keywords:
PMID:32389335 Category:Can J Cardiol Date Added:2020-05-12
Dept Affiliation: HKAP
1 Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. Electronic address: ip3@ualberta.ca.
2 Departments of Family Medicine and Community Health Services, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
3 Division of Nephrology, Department of Medicine, McGill University and Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
4 Department of Pediatrics and Centre for Outcomes Research and Evaluation, McGill University, and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.
5 Department of Medicine, University of Calgary, Libin Cardiovascular Institute of Alberta, and Alberta Kidney Disease Network, Calgary, Alberta, Canada.
6 Departments of Medicine and Community Health Sciences, O'Brien Institute for Public Health, and Libin Cardiovascular Institute, Cumming School of Medicine, Calgary, Alberta, Canada.
7 Division of Endocrinology and Metabolism, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
8 Children's Heart Centre, BC Children's Hospital, and Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.
9 Department of Nursing, Université du Québec à Trois-Rivières, Trois-Rivières, Quebec, Canada.
10 O'Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
11 Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
12 University of Ottawa and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
13 Winnipeg Regional Health Authority and the University of Manitoba, Winnipeg, Manitoba, Canada.
14 Department of Medicine, University of Toronto, and Northern Ontario School of Medicine, Sudbury, Ontario, Canada.
15 Department of Psychology, University of Calgary, Calgary, Alberta, Canada.
16 Department of Health, Kinesiology, and Applied Physiology, Concordia University, and Montreal Behavioural Medicine Centre, CIUSSS-NIM, Montréal, Quebec, Canada.
17 Division of General Internal Medicine, Departments of Medicine, Obstetrics and Gynecology, and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
18 Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
19 Centre Hospitalier Universitaire Sainte-Justine, Department of Pediatrics, Université de Montréal, Montréal, Quebec, Canada.
20 Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
21 Heart and Stroke Foundation of Canada, Ottawa, Ontario, Canada.
22 Vancouver Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
23 Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
24 Department of Medicine, McGill University, Montreal, Quebec, Canada.
25 Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
26 Faculty of Health Sciences, University of Ontario Institute of Technology, Oshawa, Ontario, Canada.
27 Department of Obstetrics and Gynecology, CHU Sainte-Justine, Université de Montréal, Quebec, Canada.
28 Service de néphrologie, Centre Hospitalier Universitaire Sainte-Justine, Université de Montréal, Montr

Description:

Hypertension Canada's 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children.

Can J Cardiol. 2020 May;36(5):596-624

Authors: Rabi DM, McBrien KA, Sapir-Pichhadze R, Nakhla M, Ahmed SB, Dumanski SM, Butalia S, Leung AA, Harris KC, Cloutier L, Zarnke KB, Ruzicka M, Hiremath S, Feldman RD, Tobe SW, Campbell TS, Bacon SL, Nerenberg KA, Dresser GK, Fournier A, Burgess E, Lindsay P, Rabkin SW, Prebtani APH, Grover S, Honos G, Alfonsi JE, Arcand J, Audibert F, Benoit G, Bittman J, Bolli P, Côté AM, Dionne J, Don-Wauchope A, Edwards C, Firoz T, Gabor JY, Gilbert RE, Grégoire JC, Gryn SE, Gupta M, Hannah-Shmouni F, Hegele RA, Herman RJ, Hill MD, Howlett JG, Hundemer GL, Jones C, Kaczorowski J, Khan NA, Kuyper LM, Lamarre-Cliche M, Lavoie KL, Leiter LA, Lewanczuk R, Logan AG, Magee LA, Mangat BK, McFarlane PA, McLean D, Michaud A, Milot A, Moe GW, Penner SB, Pipe A, Poppe AY, Rey E, Roerecke M, Schiffrin EL, Selby P, Sharma M, Shoamanesh A, Sivapalan P, Townsend RR, Tran K, Trudeau L, Tsuyuki RT, Vallée M, Woo V, Bell AD, Daskalopoulou SS

Abstract

Hypertension Canada's 2020 guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children provide comprehensive, evidence-based guidance for health care professionals and patients. Hypertension Canada develops the guidelines using rigourous methodology, carefully mitigating the risk of bias in our process. All draft recommendations undergo critical review by expert methodologists without conflict to ensure quality. Our guideline panel is diverse, including multiple health professional groups (nurses, pharmacy, academics, and physicians), and worked in concert with experts in primary care and implementation to ensure optimal usability. The 2020 guidelines include new guidance on the management of resistant hypertension and the management of hypertension in women planning pregnancy.

PMID: 32389335 [PubMed - in process]





BookR developed by Sriram Narayanan
for the Concordia University School of Health
Copyright © 2011-2026
Cookie settings
Concordia University